Literature DB >> 6344904

Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.

G Reimer, U Huschka, J Keller, R Kammerer, O P Hornstein.   

Abstract

Immunofluorescence (IF) investigations of the skin were performed in thirty patients with progressive systemic sclerosis (scleroderma) and eight patients with mixed connective tissue disease (MCTD). The results show that speckled epidermal nuclear immunoglobulin deposition occurs not only in MCTD but also in true scleroderma. Granular IgM deposition at the dermo-epidermal junction of light-exposed skin was detected in both groups of patients, but six of eight MCTD patients also showed a granular IgM band in non-exposed skin. Antinuclear antibodies (ANA) were demonstrated in the sera of 96% and 100% of patients with scleroderma and MCTD respectively. The pattern of nuclear IF staining in scleroderma included dense fine speckles, large coarse speckles, threads, nucleolar and centromere staining. In MCTD, by contrast, the ANA staining pattern consisted of threads. The significance of ANA titres and immunological specificities for the in vivo reaction of serum ANA with epidermal nuclear antigens is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344904     DOI: 10.1111/j.1365-2133.1983.tb03988.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Lymphocytotoxic autoantibodies in progressive systemic sclerosis.

Authors:  K Herrmann; J Schaller; U F Haustein; C Baldauf; S Kiessig
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.

Authors:  P J Velthuis; L Kater; I van der Tweel; F G Meyling; R H Derksen; R J Hené; J A van Geutselaar; H Baart de la Faille
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.